Related Experiment Video

Updated: Aug 20, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Lamivudine and high-dose interferon-alpha combination therapy for naive children with chronic hepatitis B infection

Inci Nur Saltik-Temizel1, Nurten Koçak, Hülya Demir

  • 1Hacettepe University, Faculty of Medicine, Department of Pediatrics, Section of Gastroenterology, Hepatology and Nutrition, Ankara, Turkey. isaltik@hacettepe.edu.tr

Journal of Clinical Gastroenterology
|December 16, 2004
PubMed

Insights

This study explored lamivudine and interferon-alpha combination therapy for children with chronic hepatitis B. The treatment showed promising results, with over half achieving virologic response and clearing hepatitis B e antigen.

Area of Science:

  • Pediatric Hepatology
  • Virology
  • Immunotherapy

Background:

  • Chronic hepatitis B affects many children, with over 50% not responding to interferon-alpha therapy alone.
  • Identifying effective treatment strategies for pediatric chronic hepatitis B is crucial.

Purpose of the Study:

  • To evaluate the efficacy of a combination therapy involving lamivudine and interferon-alpha in children with chronic hepatitis B.
  • To assess this regimen following an initial 3-month lamivudine induction phase.

Main Methods:

  • Twenty treatment-naive children received 3 months of lamivudine monotherapy.
  • Interferon-alpha was added for 6 months, followed by continued lamivudine for another 6 months.
  • Virologic response was defined by HBV DNA negativity and HBeAg loss with AntiHBe seroconversion.

Main Results:

  • Virologic response was achieved in 55% (11/20) of patients after 15 months.
  • Hepatitis B e antigen (HBeAg) clearance occurred in 60% (12/20) of patients.
  • The combination therapy was well-tolerated by the pediatric participants.

Conclusions:

  • Lamivudine and high-dose interferon-alpha combination therapy, following lamivudine induction, appears to be an effective treatment option.
  • This regimen shows potential for improving outcomes in children with chronic hepatitis B.
  • Further research may validate this approach for pediatric hepatitis B management.
Abstract

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...